Literature DB >> 20449494

Proteasome selectivity towards Michael acceptor containing oligopeptide-based inhibitors.

Wouter A van der Linden1, Paul P Geurink, Chris Oskam, Gijsbert A van der Marel, Bogdan I Florea, Herman S Overkleeft.   

Abstract

The synthesis and biological evaluation of ten Michael acceptors containing potential proteasome inhibitors are described. Cellular targets of azide containing inhibitors and were assessed in HEK293T and RAW264.7 cells by a two step labeling strategy, followed by biotin-pulldown, affinity purification, on-bead tryptic digestion and LC-MS(2) identification. This strategy appears to be an attractive alternative to gel-based competition assays.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20449494     DOI: 10.1039/b924134e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells.

Authors:  Joel D Federspiel; Simona G Codreanu; Sandeep Goyal; Matthew E Albertolle; Eric Lowe; Juli Teague; Hansen Wong; F Peter Guengerich; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2016-08-08       Impact factor: 5.911

2.  Design, Synthesis and Evaluation of Substituted Aryl-2-Nitrovinyl Derivatives as Small Molecules Proteasome Inhibitors.

Authors:  Masoud Faghih Akhlaghi; Marjan Daeihamed; Seyed Abdolmajid Ayatollahi; Farzad Kobarfard; Athar Ata
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.